From: Safety assessment of inhaled xylitol in mice and healthy volunteers
Symptom | Baseline VAS score | Change Post-saline | Change Post-10 ml xylitol | Change on day 5 follow-up |
---|---|---|---|---|
Chest tightness | 0 | 0 | 0.2 ± 0.4 | 0 |
Shortness of breath | 0 | 0 | 0 | 0 |
Cough | 0.25 ± 0.8 | 0.05 ± 0.15 | 0 | 0 |
Headache | 0 | 0 | 0.2 ± 0.6 | 0 |
Chills | 0 | 0 | 0 | 0 |
Muscle soreness | 0.2 ± 0.6 | 0 | 0 | -0.2 ± 0.6 |
Phlegm | 0.2 ± 0.6 | 0 | 0.25 ± 0.4 | 0 |
Nausea | 0 | 0 | 0 | 0 |
Stuffy/Runny Nose | 0 | 0 | 0.65 ± 0.9†| 0 |
Sneezing | 0 | 0 | 0 | 0 |
Fatigue | 0.1 ± 0.3 | 0 | -0.1 ± 0.3 | 0 |